Efficacy and Safety of Nadifloxacin for Bacterial Skin Infections: Results from Clinical and Post-Marketing Studies

INTRODUCTION: Skin and soft tissue infections involve microbial invasion of the skin and underlying soft tissues and are estimated to affect 7–10% of hospitalized patients worldwide. Nadifloxacin, a topical fluoroquinolone, has been shown to be effective against aerobic Gram-negative, Gram-positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Narayanan, Varsha, Motlekar, Salman, Kadhe, Ganesh, Bhagat, Seema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257952/
https://www.ncbi.nlm.nih.gov/pubmed/25212256
http://dx.doi.org/10.1007/s13555-014-0062-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257952/
https://www.ncbi.nlm.nih.gov/pubmed/25212256
http://dx.doi.org/10.1007/s13555-014-0062-1

Ejemplares similares